Thus, for the first time, our study showed Htr7 gene downregulation specifically in NTZ patients whose 5-HT7 receptor expression on the activated T lymphocyte surfaces was much higher than that of ARMS patients and healthy subjects. The gene discussed is HTR7; the disease is alveolar rhabdomyosarcoma.